相关实验视频

Updated: Jul 4, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

吗啡损害了未成熟的莱迪格细胞的雄激素生物合成从青春期老鼠丸体外

Yao Lv¹, Yaoyao Dong², Ming Su²

¹Department of Pharmacy, Ningbo Medical Center Lihuili Hospital, Zhejiang, Ningbo 315100, China.

Toxicology research

|January 29, 2024

概括

吗啡通过降低星和Cyp11a1基因表达的调节来抑制大鼠莱迪格细胞中的雄激素生物合成. 这种通过阿片类受体介导的效应可能会促进吗啡的产生.

科学领域:

内分泌学在内分泌学.
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

众所周知,阿片类止痛药吗啡有可能抑制雄激素生物合成.
吗啡影响莱迪格细胞产生雄激素的确切机制尚不清楚.

研究的目的:

研究吗啡对大鼠未成熟的莱迪格细胞 (ILCs) 中的雄激素分泌的直接影响.
阐明吗啡对雄激素生物合成的影响的潜在分子机制.

主要方法:

在实验室中,老鼠的ILCs与不同度的吗啡 (0.5-50μM) 进行了化.
他们分析了荷尔蒙分泌,基因表达 (Star,Cyp11a1) 和蛋白质水平 (STAR,CYP11A1).
使用纳洛评估了阿片类受体的作用.

主要成果:

吗啡显著降低了从0.5μM度开始的总安德روج因分泌.
吗啡抑制了黄素化激素 (LH) 和其他刺激的雄激素生产,但不是早期的类固醇前体.
观察到Star和Cyp11a1基因表达的下调和相应的蛋白质水平,纳洛对抗这些效应.

结论:

吗啡抑制ILC中的雄激素生物合成,可能通过μ阿片类受体.
该机制涉及Star和Cyp11a1的下调,影响类固醇生成的关键步骤.
这些发现表明,与雄激素缺乏相关的吗啡诱导副作用的潜在机制.

关键词:

止痛药是一种止痛药.产生雄激素的生产.类固醇的酶类固醇的酶.他们是阿片类受体受体.

更多相关视频

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

相关概念视频

Testosterone: Functions and Regulation

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...

Signs of Puberty

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...